Article Details

Teclistamab/Daratumumab Combo Delivers Promising ORR in Heavily Pretreated Relapsed ...

Retrieved on: 2022-05-10 17:08:04

Tags for this article:

Click the tags to see associated articles and topics

Teclistamab/Daratumumab Combo Delivers Promising ORR in Heavily Pretreated Relapsed .... View article details on hiswai:

Excerpt

Two different bispecific antibodies [were studied in this cohort]. ... Treatment with [an] anti-CD38 monoclonal antibody was allowed, ...

Article found on: www.onclive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up